Cystic Fibrosis NZ 'sets record straight on funding Trikafta for Kiwis'

On Monday 28 March, Carmen Shanks presented her Parliamentary Petition to MP Shanan Halbert, urging the Government to fund Trikafta, the first medicine that can treat the cause of cystic fibrosis for the majority of those who have the condition.

Pfizer’s oral Covid-19 treatment arrives in New Zealand

The first shipment of Pfizer’s new oral antiviral treatment for COVID-19, Paxlovid, has arrived in New Zealand and will be available for those who need it from next week.

Pharmac secures advance purchase agreement for a pre-exposure Covid-19 treatment

Pharmac has negotiated an agreement with supplier AstraZeneca for its pre-exposure prophylactic COVID-19 treatment, which would be targeted to our most vulnerable New Zealanders.

Paxlovid arrives in New Zealand - Pfizer NZ

Pfizer announced today that New Zealand has received its first delivery of PAXLOVID™ (nirmatrelvir [PF-07321332] tablets and ritonavir tablets), providing an important oral treatment for adults with COVID-19.

More Covid medicines for most at-risk New Zealanders - Little

- First batch of the 60,000 courses of Paxlovid coming this year has arrived and will be used from next week.

- Pharmac secures access to preventative COVID treatment Evusheld.

ProCare 'welcomes PHARMAC’s extended funding for flu vaccines'

ProCare welcomes PHARMAC’s decision to extend funding for this flu season to 55-64 year old Maori and Pacific people. This decision comes not long after consultation closed in which ProCare submitted in support.

Kiwis with cystic fibrosis don't have time to wait - Cystic Fibrosis NZ

A Parliamentary petition started by Carmen Shanks urging the Government to publicly fund Trikafta (a medicine that treats the underlying cause of cystic fibrosis) was presented to Labour MP Shanan Halbert, today.

ProCare supports PHARMAC’s proposal to widen access to the flu vaccine

Leading healthcare provider ProCare has today made a submission in support of PHARMAC’s proposal to widen access to the flu vaccination to an additional 39,000 Māori and Pacific people aged 55-64 for this flu season.

Pharmac to fund new treatments for lung and ovarian cancer

Pharmac has confirmed today they are funding a bundle deal which will give New Zealanders more effective treatment options for lung cancer and ovarian cancer. The bundle deal also includes a new medicine for people with severe eosinophilic asthma.

Pharmac deal good news for New Zealanders - Andrew Little

The Government is welcoming news the national drug-funding agency Pharmac has secured an agreement for medicines that will help New Zealanders with lung cancer, ovarian cancer and severe asthma.